SciELO - Scientific Electronic Library Online

 
vol.36 issue2Progressive disseminated histoplasmosis in a cohort of patients with HIV coinfectionRelationship between insulinemia and fatty liver in patients with normal body mass index and without a history of chronic alcohol consumption or diabetes mellitus author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Acta Medica Colombiana

Print version ISSN 0120-2448

Abstract

SENIOR, Juan Manuel; SALDARRIAGA, Clara Inés; ARISTIZABAL, Julián Miguel  and  RENDON, Jairo Alonso. Safety and effectiveness of levosimendan administration without loading dose in a specialized heart failure unit. Acta Med Colomb [online]. 2011, vol.36, n.2, pp.68-72. ISSN 0120-2448.

Objective: to evaluate the safety and effectiveness of levosimendan administration in patients with chronic heart failure, signs of low output, and indications for inotropic therapy. The protocol included a continuous infusion of levosimendan without loading dose, with a total dosage of 12.5 miligrams. Methods: a retrospective, descriptive study was performed to evaluate changes in mean arterial pressure, the development of arrhythmias, adverse effects like death during the infusion, and functional changes in the two months after the treatment. Results: the infusion was well tolerated, without side effects. Mean arterial pressure before the infusion was 71± 21.6 vs. 75 ± 20.9 mmHg 24 hours after and 71 ± 21.6 vs. 71.6 ± 21.4 48 hours after. There was one death (4.7%), explained by non-cardiovascular causes (sepsis). An improvement in functional class was observed during the follow-up. Conclusion: this report of an initial experience suggests that the administration of levosimendan infusion without loading dose is safe and can be used outside the intensive care unit (Acta Med Colomb 2011: 36: 68-72).

Keywords : heart failure; therapeutics; cardiotonic agents; effectiveness.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License